FAM72B Inhibitors

FAM72B inhibitors primarily revolve around compounds that are capable of modulating cell cycle and proliferation, given the protein's proposed association with these biological processes. Chemicals like Palbociclib and AZD5438 are designed to target cyclin-dependent kinases (CDKs), critical regulators of the cell cycle. The inhibition of these kinases can alter cell cycle dynamics, possibly intersecting with the pathways or processes that FAM72B is involved in. Furthermore, agents such as U0126 and PD98059 focus on the MEK pathway, a crucial regulator of cell proliferation. Inhibition here can alter cellular signaling in a manner that potentially modulates FAM72B's function. The PI3K pathway, targeted by compounds like LY294002 and Wortmannin, is instrumental in cell growth and survival. By blocking this pathway, cells might experience shifts in their growth and survival dynamics, which can intersect with the biological processes in which FAM72B plays a role. Similarly, mTOR, a central regulator of cell growth, is the target of Rapamycin. Inhibition of mTOR can bring about changes in cellular growth dynamics that may overlap with FAM72B's function.